Published in Neuropediatrics on June 01, 2002
Isolated cytochrome c oxidase deficiency as a cause of MELAS. BMJ Case Rep (2009) 0.76
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92
Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat Genet (2001) 2.52
Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. NMR Biomed (2001) 2.29
Episodic variations of prolactin, thyroid-stimulating hormone, luteinizing hormone, melatonin and cortisol in infertile women with subclinical hypothyroidism. Hum Reprod (1997) 2.23
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett (1995) 2.19
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet (2001) 2.06
Network atrophy in temporal lobe epilepsy: a voxel-based morphometry study. Neurology (2008) 2.03
The preparation and execution of self-initiated and externally-triggered movement: a study of event-related fMRI. Neuroimage (2002) 2.01
Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann Neurol (2000) 2.01
The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development. Development (1994) 1.98
Essential role of Gab1 for signaling by the c-Met receptor in vivo. J Cell Biol (2000) 1.97
Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet (1999) 1.93
Fractal analysis: an objective method for identifying atypical nuclei in dysplastic lesions of the cervix uteri. Gynecol Oncol (1999) 1.74
Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann Neurol (1999) 1.74
Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation (1995) 1.71
Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis. AJNR Am J Neuroradiol (2007) 1.70
Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study. Eur J Nucl Med (1997) 1.66
Dielectric spectroscopy of single human erythrocytes at physiological ionic strength: dispersion of the cytoplasm. Biophys J (1996) 1.66
The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of beta-catenin/Tcf/Lef signaling. J Biol Chem (2000) 1.65
A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins. Virology (1998) 1.60
High-resolution MR venography at 3.0 Tesla. J Comput Assist Tomogr (2000) 1.57
Finger somatotopy in human motor cortex. Neuroimage (2001) 1.53
[Could C- and D-network mobile phones endanger patients with pacemakers?]. Dtsch Med Wochenschr (1996) 1.52
Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. AJNR Am J Neuroradiol (2001) 1.51
Clinical and neuropsychological outcome in 33 patients with biotinidase deficiency ascertained by nationwide newborn screening and family studies in Austria. Eur J Pediatr (2001) 1.50
Suppression of gastric acid increases the risk of developing immunoglobulin E-mediated drug hypersensitivity: human diclofenac sensitization and a murine sensitization model. Clin Exp Allergy (2009) 1.48
The activity of NF-kappaB in Swiss 3T3 cells exposed to aqueous extracts of cigarette smoke is dependent on thioredoxin. Toxicol Sci (2001) 1.48
Increased prevalence of obstructive sleep apnoea in patients with Charcot-Marie-Tooth disease: a case control study. J Neurol Neurosurg Psychiatry (2008) 1.47
Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet (1999) 1.46
Occurrence of Andermann syndrome out of French Canada--agenesis of the corpus callosum with neuronopathy. Neuropediatrics (1993) 1.46
Three-dimensional electric field traps for manipulation of cells--calculation and experimental verification. Biochim Biophys Acta (1993) 1.45
Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy. Eur J Endocrinol (1995) 1.45
MAP1B is required for axon guidance and Is involved in the development of the central and peripheral nervous system. J Cell Biol (2000) 1.44
Latex sensitization in spina bifida appears disease-associated. J Pediatr (1999) 1.43
Fuzzy clustering of gradient-echo functional MRI in the human visual cortex. Part I: reproducibility. J Magn Reson Imaging (1998) 1.42
BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity. Mol Pharmacol (2001) 1.41
Assessment of (31)P relaxation times in the human calf muscle: a comparison between 3 T and 7 T in vivo. Magn Reson Med (2009) 1.40
Kinetics of pulmonary leukocyte sequestration in man during hemodialysis with different membrane-types. Int J Artif Organs (1990) 1.40
In vivo quantification of intracerebral GABA by single-voxel (1)H-MRS-How reproducible are the results? Eur J Radiol (2009) 1.38
Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol (2000) 1.37
Human rabies due to lyssavirus infection of bat origin. Vet Microbiol (2010) 1.37
Disruption of nigrostriatal and cerebellothalamic pathways in dopamine responsive Holmes' tremor. J Neurol Neurosurg Psychiatry (2008) 1.33
A role of the cryptic gene in the correct establishment of the left-right axis. Curr Biol (1999) 1.33
Association of human protein-tyrosine phosphatase kappa with members of the armadillo family. J Biol Chem (1996) 1.33
Cellular redistribution of protein tyrosine phosphatases LAR and PTPsigma by inducible proteolytic processing. J Cell Biol (1997) 1.33
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology (2001) 1.32
Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med (2001) 1.32
Complement activation by recombinant adenoviruses. Gene Ther (2001) 1.31
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer (2001) 1.30
Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene. Neurology (2005) 1.28
POU transcription factors control expression of CNS stem cell-specific genes. Development (1998) 1.28
Effect of local low-dose thrombolysis on clinical outcome in acute embolic renal artery occlusion. Radiology (1993) 1.27
Pipecolic acid as a diagnostic marker of pyridoxine-dependent epilepsy. Neuropediatrics (2005) 1.27
Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg (1996) 1.24
Association of mitochondria with plectin and desmin intermediate filaments in striated muscle. Exp Cell Res (1999) 1.24
A hierarchical clustering method for analyzing functional MR images. Magn Reson Imaging (1999) 1.23
Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet (2001) 1.23
Traveling-wave dielectrophoresis of microparticles. Electrophoresis (1992) 1.23
Optimized 3 T EPI of the amygdalae. Neuroimage (2004) 1.23
1H NMR relaxation times of skeletal muscle metabolites at 3 T. MAGMA (2004) 1.22
Cell manipulation and cultivation under a.c. electric field influence in highly conductive culture media. Biochim Biophys Acta (1994) 1.22
Proton NMR relaxation times of human blood samples at 1.5 T and implications for functional MRI. Cell Mol Biol (Noisy-le-grand) (1997) 1.22
Direct visualization of the dystrophin network on skeletal muscle fiber membrane. J Cell Biol (1992) 1.22
Quantification in functional magnetic resonance imaging: fuzzy clustering vs. correlation analysis. Magn Reson Imaging (1998) 1.22
Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET? Ann Oncol (2005) 1.21
Levitation, holding, and rotation of cells within traps made by high-frequency fields. Biochim Biophys Acta (1992) 1.19
TPK1, a Ca(2+)-regulated Arabidopsis vacuole two-pore K(+) channel is activated by 14-3-3 proteins. Plant J (2007) 1.19
Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol (2005) 1.18
Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging (1998) 1.18
Transfer function analysis for clinical evaluation of dynamic cerebral autoregulation--a comparison between spontaneous and respiratory-induced oscillations. Physiol Meas (2003) 1.18
Identification of RELMgamma, a novel resistin-like molecule with a distinct expression pattern. Genomics (2003) 1.17
Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma? Eur J Neurol (2009) 1.17
Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology (2001) 1.17
Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes (1999) 1.16
Cloning and functional expression of GABA(B) receptors from Drosophila. Eur J Neurosci (2001) 1.16
Bat rabies surveillance in Europe. Zoonoses Public Health (2012) 1.15
Population dynamics and antagonistic potential of enterococci colonizing the phyllosphere of grasses. J Appl Microbiol (2001) 1.15
Two novel mutations in the GDAP1 and PRX genes in early onset Charcot-Marie-Tooth syndrome. Neuropediatrics (2008) 1.15
Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol (2001) 1.15
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med (2001) 1.15
Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. J Gen Virol (2001) 1.14
Effect of carotid endarterectomy or stenting on impairment of dynamic cerebral autoregulation. Stroke (2004) 1.14
Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. EMBO J (1993) 1.14
A novel organotypic long-term culture of the rat hippocampus on substrate-integrated multielectrode arrays. Brain Res Brain Res Protoc (1998) 1.14
Gauss sum factorization with cold atoms. Phys Rev Lett (2008) 1.14
Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging (2004) 1.13
Cerebral autoregulation in carotid artery occlusive disease assessed from spontaneous blood pressure fluctuations by the correlation coefficient index. Stroke (2003) 1.13
Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation. Neuroreport (2001) 1.13
Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis (2010) 1.13
Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related? J Pathol (2006) 1.12
Deciphering serology to understand the ecology of infectious diseases in wildlife. Ecohealth (2013) 1.12
Fully exploratory network ICA (FENICA) on resting-state fMRI data. J Neurosci Methods (2010) 1.12